{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-012630","form_type":"8-K","ticker":"PRPH","cik":"0000868278","company_name":"ProPhase Labs, Inc.","filed_at":"2022-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.030269+00:00","generated_at":"2026-06-25T22:07:23.296437+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"ProPhase Labs appoints Bill White as CFO effective May 23, 2022","bullets":["Bill White, 61, replaces Monica Brady, who becomes CAO and CFO of subsidiary ProPhase Diagnostics.","White previously CFO/COO of Intellicheck (IDN); over 30 years financial management experience.","Salary $350k; minimum 2022 bonus $50k; inducement option for 400k shares at $6.74, vesting 4 years.","Severance: 6 months salary if terminated without cause before 1 year; 12 months after 1 year.","Inducement option exempt from stockholder approval per Nasdaq Rule 5635(c)(4)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-012630","json":"https://secwatch.observer/filing/0001493152-22-012630.json","markdown":"https://secwatch.observer/filing/0001493152-22-012630.md","text":"https://secwatch.observer/filing/0001493152-22-012630.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/868278/000149315222012630/0001493152-22-012630-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/868278/000149315222012630/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T22:07:23.296437+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1cac24a6ba","claim":"Bill White was appointed as Chief Financial Officer at ProPhase Labs, Inc..","evidence_excerpt":"On May 9, 2022, ProPhase Labs, Inc. (the “Company”) announced that it will appoint Bill White, age 61, as Chief Financial Officer of the Company, effective May 23, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222012630/0001493152-22-012630-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"3a9b854b3a","claim":"Monica Brady changed role as Chief Accounting Officer and Chief Financial Officer of subsidiary at ProPhase Labs, Inc..","evidence_excerpt":"Ms. Brady will remain with the Company and continue to serve as the Company’s Chief Accounting Officer, and Chief Financial Officer of the Company’s wholly-owned subsidiary, ProPhase Diagnostics, Inc., as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222012630/0001493152-22-012630-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"replaced"},{"label":"Role","value":"Chief Accounting Officer and Chief Financial Officer of subsidiary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}